questionsmedicales.fr
Phénomènes physiologiques
Phénomènes pharmacologiques et toxicologiques
Pharmacocinétique
Équivalence thérapeutique
Équivalence thérapeutique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Équivalence thérapeutique
Études cliniques
Bioéquivalence
Pharmacocinétique
Normes de qualité
Sécurité des médicaments
ANSM
Agences de régulation
Critères d'inclusion
Population cible
Symptômes
5
Effets indésirables
Efficacité thérapeutique
Réaction allergique
Éruption cutanée
Inefficacité
Symptômes cliniques
Variabilité des symptômes
Composition des médicaments
Symptômes graves
Consultation médicale
Prévention
5
Erreurs de traitement
Éducation des patients
Bonnes pratiques
Allergies médicamenteuses
Information des patients
Consultations médicales
Logiciels de prescription
Alertes de sécurité
Choix de traitement
Réduction des coûts
Traitements
5
Médicaments génériques
Médicaments de marque
Tolérance au traitement
Coût des médicaments
Effets cliniques
Effets secondaires
Sécurité des traitements
Rapports d'effets indésirables
Ajustement de dose
Pharmacothérapie
Complications
5
Réactions allergiques
Interactions médicamenteuses
Gestion des complications
Consultation médicale
Antécédents médicaux
Prévisibilité des complications
Douleurs thoraciques
Difficultés respiratoires
Suivi médical
Communication médecin-patient
Facteurs de risque
5
Échec thérapeutique
Comorbidités
Adhérence au traitement
Efficacité thérapeutique
Antécédents médicaux
Réactions aux médicaments
Facteurs environnementaux
Mode de vie
Évaluation des risques
Historique médical
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Équivalence thérapeutique : Questions médicales les plus fréquentes",
"headline": "Équivalence thérapeutique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Équivalence thérapeutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Équivalence thérapeutique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pharmacocinétique",
"url": "https://questionsmedicales.fr/mesh/D010599",
"about": {
"@type": "MedicalCondition",
"name": "Pharmacocinétique",
"code": {
"@type": "MedicalCode",
"code": "D010599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G07.690.725"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Équivalence thérapeutique",
"alternateName": "Therapeutic Equivalency",
"code": {
"@type": "MedicalCode",
"code": "D013810",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sean M Hays",
"url": "https://questionsmedicales.fr/author/Sean%20M%20Hays",
"affiliation": {
"@type": "Organization",
"name": "Summit Toxicology, LLC, Bozeman, MT, USA. Electronic address: shays@summittoxicology.com."
}
},
{
"@type": "Person",
"name": "Erik Arntzen",
"url": "https://questionsmedicales.fr/author/Erik%20Arntzen",
"affiliation": {
"@type": "Organization",
"name": "Department of Behavioral Science, Oslo Metropolitan University, Oslo 0167, Norway erik.arntzen@equivalence.net."
}
},
{
"@type": "Person",
"name": "Christopher R Kirman",
"url": "https://questionsmedicales.fr/author/Christopher%20R%20Kirman",
"affiliation": {
"@type": "Organization",
"name": "Summit Toxicology, LLC, Bozeman, MT, USA."
}
},
{
"@type": "Person",
"name": "Sanjay Kalra",
"url": "https://questionsmedicales.fr/author/Sanjay%20Kalra",
"affiliation": {
"@type": "Organization",
"name": "Department of Endocrinology, Bharti Hospital, Karnal, India."
}
},
{
"@type": "Person",
"name": "Laxmaiah Manchikanti",
"url": "https://questionsmedicales.fr/author/Laxmaiah%20Manchikanti",
"affiliation": {
"@type": "Organization",
"name": "Pain Management Centers of America, Paducah, KY and Evansville, IN"
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Psychometric evaluation of the WHODAS 2.0 and prevalence of disability in a Swedish general population.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37020121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41687-023-00580-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health disparities associated with access to disability evaluations for toddlers in Early Head Start.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36575049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jir.13003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multidimensional Disability Evaluation and Confirmatory Analysis of Older Adults in a Home-Based Community in China.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35801251",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.899303"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36142563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms231810651"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health professionals' experiences with the PEDI-UG: What do Ugandan occupational therapists say about the utility and value of the Pediatric Evaluation of Disability Inventory (PEDI-UG) for children with disabilities?",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36251008",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cch.13071"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques",
"item": "https://questionsmedicales.fr/mesh/D010829"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes pharmacologiques et toxicologiques",
"item": "https://questionsmedicales.fr/mesh/D002620"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pharmacocinétique",
"item": "https://questionsmedicales.fr/mesh/D010599"
},
{
"@type": "ListItem",
"position": 5,
"name": "Équivalence thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013810"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Équivalence thérapeutique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Équivalence thérapeutique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Équivalence thérapeutique",
"description": "Comment évaluer l'équivalence thérapeutique ?\nQuels tests sont utilisés pour l'équivalence ?\nQuelles sont les normes d'évaluation ?\nQui réalise les évaluations d'équivalence ?\nQuels sont les critères d'inclusion ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Équivalence thérapeutique",
"description": "Quels symptômes indiquent une non-équivalence ?\nComment reconnaître une réaction allergique ?\nQuels signes d'inefficacité observer ?\nLes symptômes varient-ils selon les traitements ?\nQuels symptômes nécessitent un avis médical ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Équivalence thérapeutique",
"description": "Comment prévenir les erreurs de traitement ?\nQuelles sont les bonnes pratiques de prescription ?\nComment informer les patients sur l'équivalence ?\nQuels outils aident à la prévention des erreurs ?\nPourquoi est-il important de connaître l'équivalence ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Équivalence thérapeutique",
"description": "Quels traitements sont souvent équivalents ?\nComment choisir entre deux traitements équivalents ?\nLes traitements équivalents ont-ils les mêmes effets ?\nComment évaluer la sécurité des traitements ?\nLes traitements équivalents nécessitent-ils des doses différentes ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Équivalence thérapeutique",
"description": "Quelles complications peuvent survenir avec des traitements équivalents ?\nComment gérer les complications liées aux traitements ?\nLes complications sont-elles prévisibles ?\nQuels sont les signes d'une complication grave ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Équivalence thérapeutique",
"description": "Quels facteurs augmentent le risque d'échec thérapeutique ?\nComment l'adhérence au traitement affecte-t-elle l'équivalence ?\nLes antécédents médicaux influencent-ils l'équivalence ?\nQuels facteurs environnementaux jouent un rôle ?\nComment évaluer les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D013810?mesh_terms=Disability+Evaluation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'équivalence thérapeutique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des études cliniques comparatives et des méta-analyses."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'équivalence ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de bioéquivalence et des études de pharmacocinétique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelles sont les normes d'évaluation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les normes incluent des critères de sécurité, d'efficacité et de qualité des médicaments."
}
},
{
"@type": "Question",
"name": "Qui réalise les évaluations d'équivalence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les agences de régulation, comme l'ANSM, et des chercheurs indépendants effectuent ces évaluations."
}
},
{
"@type": "Question",
"name": "Quels sont les critères d'inclusion ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la population cible, les indications et les méthodes de traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une non-équivalence ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets indésirables ou une efficacité réduite peuvent signaler une non-équivalence."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruption cutanée, démangeaisons, et gonflement après administration."
}
},
{
"@type": "Question",
"name": "Quels signes d'inefficacité observer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence d'amélioration des symptômes après un traitement peut indiquer une inefficacité."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les traitements ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent provoquer des symptômes différents selon leur composition."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un avis médical ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves ou persistants après un traitement doivent être évalués par un médecin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les erreurs de traitement ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vérification des prescriptions et l'éducation des patients sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles sont les bonnes pratiques de prescription ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des protocoles standardisés et vérifier les allergies des patients."
}
},
{
"@type": "Question",
"name": "Comment informer les patients sur l'équivalence ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournir des brochures et des consultations pour expliquer les options de traitement."
}
},
{
"@type": "Question",
"name": "Quels outils aident à la prévention des erreurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des logiciels de gestion des prescriptions et des alertes de sécurité peuvent aider."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de connaître l'équivalence ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela permet de choisir le traitement le plus approprié et de réduire les coûts."
}
},
{
"@type": "Question",
"name": "Quels traitements sont souvent équivalents ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les génériques et les médicaments de marque pour la même indication sont souvent équivalents."
}
},
{
"@type": "Question",
"name": "Comment choisir entre deux traitements équivalents ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend de la tolérance, du coût et des préférences du patient."
}
},
{
"@type": "Question",
"name": "Les traitements équivalents ont-ils les mêmes effets ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent avoir des effets cliniques similaires, mais peuvent différer en effets secondaires."
}
},
{
"@type": "Question",
"name": "Comment évaluer la sécurité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sécurité est évaluée par des études cliniques et des rapports d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les traitements équivalents nécessitent-ils des doses différentes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des ajustements peuvent être nécessaires selon le patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des traitements équivalents ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des réactions allergiques ou des interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial d'arrêter le traitement et de consulter un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles, surtout avec des antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication grave ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des douleurs thoraciques ou des difficultés respiratoires sont alarmants."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une communication ouverte avec le médecin sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'échec thérapeutique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, les comorbidités et l'adhérence au traitement influencent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'adhérence au traitement affecte-t-elle l'équivalence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise adhérence peut réduire l'efficacité, rendant l'équivalence difficile à évaluer."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils l'équivalence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions aux médicaments peuvent affecter le choix du traitement."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux jouent un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'alimentation, le mode de vie et l'exposition à des toxines peuvent influencer."
}
},
{
"@type": "Question",
"name": "Comment évaluer les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation complète de l'historique médical et des habitudes de vie est nécessaire."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Summit Toxicology, LLC, Bozeman, MT, USA. Electronic address: shays@summittoxicology.com.
Publications dans "Équivalence thérapeutique" :
3 publications dans cette catégorie
Affiliations :
Department of Behavioral Science, Oslo Metropolitan University, Oslo 0167, Norway erik.arntzen@equivalence.net.
Publications dans "Équivalence thérapeutique" :
3 publications dans cette catégorie
Affiliations :
Summit Toxicology, LLC, Bozeman, MT, USA.
Publications dans "Équivalence thérapeutique" :
3 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Bharti Hospital, Karnal, India.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Pain Management Centers of America, Paducah, KY and Evansville, IN
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Pain Management Centers of America, Paducah, KY.
Pain Management Centers of America, Evansville, IN.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Pain Management Centers of America, Paducah, KY.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Pain Management Centers of America, Evansville, IN.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Department of Computer Science, Oslo Metropolitan University, Oslo 0167, Norway Anis.Yazidi@oslomet.no.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Department of Computer Science, Oslo Metropolitan University, Oslo 0167, Norway Hugo.Hammer@oslomet.no.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Tetra Tech, Inc, Denver, CO, USA.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Tetra Tech, Inc, Denver, CO, USA.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, BPS Government Medical College, Khanpur Kalan, Sonepat, India.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, CEDAR Clinic, Panipat, India.
Publications dans "Équivalence thérapeutique" :
2 publications dans cette catégorie
Affiliations :
Health Canada, Ottawa, ON, Canada. Electronic address: devika.poddalgoda@canada.ca.
Publications dans "Équivalence thérapeutique" :
1 publication dans cette catégorie
Affiliations :
Department of Orthopaedic Surgery, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Department of Biomedical Engineering, University of Connecticut, 260 Glenbrook Road, Unit 3247, Storrs, CT, 06269, USA.
Publications dans "Équivalence thérapeutique" :
1 publication dans cette catégorie
Affiliations :
Department of Orthopaedic Surgery, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Department of Biomedical Engineering, University of Connecticut, 260 Glenbrook Road, Unit 3247, Storrs, CT, 06269, USA.
Publications dans "Équivalence thérapeutique" :
1 publication dans cette catégorie
Affiliations :
Department of Orthopaedic Surgery, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Department of Biomedical Engineering, Western New England University, 1215 Wilbrahan Road, Springfield, MA, 01119, USA.
Publications dans "Équivalence thérapeutique" :
1 publication dans cette catégorie
Affiliations :
Department of Orthopaedic Surgery, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Department of Pharmaceutical Sciences, School of Pharmacy, University of Saint Joseph, 229 Trumbull St, Hartford, CT, 06103, USA.
Publications dans "Équivalence thérapeutique" :
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic questionnaire that captures health and disability-related functioning information corresponding to six major life...
A cross-sectional survey was performed. Internal consistency reliability was assessed with Cronbach's alpha. The construct validity was evaluated with item-total correlation, Pearson's correlation bet...
Three thousand four hundred and eighty two adults aged 19-103 years (response rate 43%) participated. Significantly higher degrees of disability were reported by the oldest age group (≥ 80 years), adu...
The psychometric properties of the self-administered Swedish 36-item version of the WHODAS 2.0 are comparable to those of other language versions of the instrument. Data of the prevalence of disabilit...
The aim of this investigation was to examine developmental, sociodemographic and familial factors associated with parent reported access to an evaluation in an Early Head Start sample. Children with d...
This study (n = 191) examined how developmental, sociodemographic and parent factors at age 2 were associated with parent reporting the child being evaluated by age 3. Two logistic regression analyses...
The first model found that children in the monitoring zone of developmental risk were more likely to be evaluated per parent report if they were born preterm, male, with increased behaviour problems, ...
This study highlights barriers associated with access to developmental and disability evaluations for children in at-risk families. Health disparities are negatively associated with children's access ...
A robust multi-dimensional disability assessment standard was constructed to consider physical condition, care resources, and social interaction that might lead to disability, to provide a basis for a...
Short-term disability progression was predicted from a baseline evaluation in patients with multiple sclerosis (MS) using their three-dimensional T1-weighted (3DT1) magnetic resonance images (MRI). On...
The Uganda version of Pediatric Evaluation of Disability Inventory (PEDI-UG) was culturally adapted and validated from the PEDI-US, a tool used to evaluate the functional capability of children with o...
A qualitative research design was chosen to explore the participants' viewpoints concerning the utility and value of the PEDI-UG for children with disabilities. Purposive sampling was used to recruit ...
Several challenges concerning the contextual use of PEDI-UG were reported. For example, PEDI-UG being culturally adapted in two languages (English and Luganda) makes it difficult for health profession...
The findings of this study suggest that health professionals are challenged with the use of the PEDI-UG assessment in diverse cultural contexts and/or languages. These challenges are important conside...
The prevention of disability over the long term is the main treatment goal in multiple sclerosis (MS); however, randomized clinical trials evaluate only short-term treatment effects on disability. Thi...
In total, 14,802 6-month confirmed disability progression events were identified in 8741 patients from the global MSBase registry. For each 6-month confirmed progression event (13,321 in the developme...
The score was based on age, sex, MS phenotype, relapse activity, disability score and its change from baseline, number of affected functional system domains and worsening in six of the domains. In the...
Clinicodemographic characteristics of 6-month confirmed disability progression events identify those at high risk of sustained long-term disability. This knowledge will allow future trials to better a...
Our objectives were to examine cross-sectional correlations of headache disability with measures of resilience, anxiety, and depression, and to determine if resilience modified the association between...
Resilience is associated with quality of life and functioning among patients with chronic conditions. We investigated whether resilience strongly mitigates headache-related disability as measured by t...
We prospectively recruited 160 patients with primary headache disorders seen in a tertiary headache medicine program between February 20, 2018 and August 2, 2019. Each participant completed the MIDAS,...
The CDRS-25 score was negatively correlated with the total MIDAS (r = -0.21, p = 0.009), GAD-7 (r = -0.56, p < 0.001), and PHQ-9 scores (r = -0.34, p < 0.001). Well-being inversely correlated with dis...
Traits associated with resilience decreased the odds of severe disability from headaches, whereas anxiety, depression, and headache frequency were strongly associated with higher disability from heada...
To investigate clinically meaningful change for ROADS and ALSFRS-R using a patient-defined approach....
Data were reviewed from participants assessed at the Emory ALS Center from 2019-2022 with two assessments using both ROADS and ALSFRS-R and a completed patient-reported global impression of change sca...
Data were included from 162 participants. For ROADS (total possible normed score = 146), MID = 5.81 and MDC = 2.83 points. For ALSFRS-R (total possible sum-score = 48), MID = 3.24 and MDC = 1.59 point...
Changes that are on average less than 5.81 points (3.98%) on the normed ROADS score or less than 3.24 points (6.75%) on the ALSFRS-R sum-score may not be clinically meaningful according to a patient-d...
To evaluate the impact and acceptability of outpatient physical or occupational therapy (PT/OT) for breast cancer survivors (BCS) with varying levels of upper extremity disability (UED)....
We retrospectively extracted patient and therapy characteristics, UED measured by quick-disabilities of the arm, shoulder and hand (QuickDASH, 0-100 pts.), and patient-rated acceptability (1-item, 0-1...
Patients (N = 417) were 59.89 ± 12.06 years old, 99% female, and attended approximately 10 PT/OT sessions (IQR = 6.0-16.0). Most had high baseline UED (62%), followed by moderate (25%) or low UED (13%...
Outpatient cancer rehabilitation is associated with significant improvement in UED for BCS and was acceptable to patients regardless of UED severity at baseline....
To ensure the validity and therapeutic utility of the Neck disability index (NDI) scale, translations, cultural adaptations and psychometric evidence is necessary. This study aimed to address the abse...
Following guidelines provided by the American Association of Orthopedic Surgeons, the original English NDI scale was cross-culturally adapted into Hindi. The adaptation process included translations (...
The NDI-Hi version exhibited favorable psychometric properties, including good test-retest reliability with an intra-class correlation coefficient (ICC) of 0.87. Internal consistency of the scale was ...
The NDI-Hi demonstrated validity and reliability as an outcome tool for assessing neck disability. It can be effectively utilized in clinical practice and research settings involving Hindi-speaking in...